Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy
Abstract T-cell immunoglobulin mucin 3 (TIM-3) has emerged as a promising immune checkpoint target in cancer therapy. However, the profile…
Abstract T-cell immunoglobulin mucin 3 (TIM-3) has emerged as a promising immune checkpoint target in cancer therapy. However, the profile…